SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
biogen
biogen
Aging Well
Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug
By
Lindsey Leake
February 6, 2025
Health
First-of-its-kind drug for rare form of Lou Gehrig’s disease gets FDA approval
By
Matthew Perrone
and
The Associated Press
April 25, 2023
Health
Alzheimer’s drug approval by FDA ‘rife with irregularities,’ Congress finds after 18-month investigation
By
The Associated Press
December 30, 2022
Health
Congressional investigators say the FDA’s controversial approval of Biogen’s Alzheimer’s drug Aduhelm was ‘rife with irregularities’
By
Fiona Rutherford
,
Celine Castronuovo
and
Bloomberg
December 30, 2022
Health
Breakthrough Alzheimer’s trial results show experimental drug significantly slows the disease
By
Michelle Fay Cortez
and
Bloomberg
September 28, 2022
Health
Inside the lobbying push to get Medicare to pay for a controversial Alzheimer’s drug
By
Arthur Allen
and
Kaiser Health News
February 16, 2022
Health
Medicare ordered to reassess premium hike for Alzheimer’s drug
By
Ricardo Alonso-Zaldivar
and
The Associated Press
January 10, 2022
Health
Biogen slashes cost of Alzheimer’s drug by 50% six months after FDA approval
By
Timothy Annett
and
Bloomberg
December 20, 2021
Newsletters
The spread of the ‘Delta Plus’ subvariant is a reminder of where visions of our COVID future diverge
By
David Meyer
November 18, 2021
Newsletters
Medical boards are still struggling to discipline doctors who spread COVID-19 myths
By
Yasmin Tayag
November 11, 2021
Newsletters
Medicare negotiating drug prices could be the game changer Americans need
By
Yasmin Tayag
November 4, 2021
Newsletters
COVID vaccines could be the key to solving the global youth mental health emergency
By
Yasmin Tayag
October 28, 2021
Most Popular
Retail
Walmart and Target are allegedly forcing employees to remove tags on apparel to make it easier to jack up prices based...
By
Erin Cabrey
and
Retail Brew
Economy
Ray Dalio says 'most people are silent' because they're afraid to talk about what's really happening with the U.S....
By
Dave Smith
Success
Unemployed graduates are flocking to this business degree to stand out in the current job market. Unlike most MBAs it...
By
Emma Burleigh